Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
2011
|
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044845034 | ||
| 003 | DE-604 | ||
| 005 | 20180305 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 180305s2011 xx o|||| 00||| eng d | ||
| 020 | |a 9780309163248 |9 978-0-309-16324-8 | ||
| 020 | |a 0309163242 |9 0-309-16324-2 | ||
| 035 | |a (ZDB-38-ESG)ebr10443278 | ||
| 035 | |a (OCoLC)707927323 | ||
| 035 | |a (DE-599)BVBBV044845034 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Mack, Alison |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Perspectives on biomarker and surrogate endpoint evaluation |b discussion forum summary |c Alison Mack, Erin Balogh, and Christine M. Micheel ; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c 2011 | |
| 300 | |a x, 129 p | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 505 | 8 | |a Includes bibliographical references (p. 99-102) | |
| 650 | 4 | |a Biochemical markers | |
| 655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Balogh, Erin |e Sonstige |4 oth | |
| 700 | 1 | |a Micheel, Christine |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |e Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease |4 oth | |
| 912 | |a ZDB-38-ESG | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-030239896 | |
Datensatz im Suchindex
| _version_ | 1819301719981424640 |
|---|---|
| any_adam_object | |
| author | Mack, Alison |
| author_facet | Mack, Alison |
| author_role | aut |
| author_sort | Mack, Alison |
| author_variant | a m am |
| building | Verbundindex |
| bvnumber | BV044845034 |
| collection | ZDB-38-ESG |
| contents | Includes bibliographical references (p. 99-102) |
| ctrlnum | (ZDB-38-ESG)ebr10443278 (OCoLC)707927323 (DE-599)BVBBV044845034 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01467nam a2200361zc 4500</leader><controlfield tag="001">BV044845034</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180305 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180305s2011 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309163248</subfield><subfield code="9">978-0-309-16324-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309163242</subfield><subfield code="9">0-309-16324-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-38-ESG)ebr10443278</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)707927323</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044845034</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mack, Alison</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Perspectives on biomarker and surrogate endpoint evaluation</subfield><subfield code="b">discussion forum summary</subfield><subfield code="c">Alison Mack, Erin Balogh, and Christine M. Micheel ; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">x, 129 p</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Includes bibliographical references (p. 99-102)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemical markers</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Balogh, Erin</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Micheel, Christine</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="e">Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-38-ESG</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030239896</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV044845034 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-24T06:22:04Z |
| institution | BVB |
| isbn | 9780309163248 0309163242 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030239896 |
| oclc_num | 707927323 |
| open_access_boolean | |
| physical | x, 129 p |
| psigel | ZDB-38-ESG |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Mack, Alison Verfasser aut Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary Alison Mack, Erin Balogh, and Christine M. Micheel ; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease Washington, D.C. National Academies Press 2011 x, 129 p txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references (p. 99-102) Biochemical markers 1\p (DE-588)1071861417 Konferenzschrift gnd-content Balogh, Erin Sonstige oth Micheel, Christine Sonstige oth Institute of Medicine (U.S.) Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Mack, Alison Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary Includes bibliographical references (p. 99-102) Biochemical markers |
| subject_GND | (DE-588)1071861417 |
| title | Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary |
| title_auth | Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary |
| title_exact_search | Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary |
| title_full | Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary Alison Mack, Erin Balogh, and Christine M. Micheel ; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease |
| title_fullStr | Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary Alison Mack, Erin Balogh, and Christine M. Micheel ; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease |
| title_full_unstemmed | Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary Alison Mack, Erin Balogh, and Christine M. Micheel ; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease |
| title_short | Perspectives on biomarker and surrogate endpoint evaluation |
| title_sort | perspectives on biomarker and surrogate endpoint evaluation discussion forum summary |
| title_sub | discussion forum summary |
| topic | Biochemical markers |
| topic_facet | Biochemical markers Konferenzschrift |
| work_keys_str_mv | AT mackalison perspectivesonbiomarkerandsurrogateendpointevaluationdiscussionforumsummary AT balogherin perspectivesonbiomarkerandsurrogateendpointevaluationdiscussionforumsummary AT micheelchristine perspectivesonbiomarkerandsurrogateendpointevaluationdiscussionforumsummary AT instituteofmedicineus perspectivesonbiomarkerandsurrogateendpointevaluationdiscussionforumsummary |